BACKGROUND
While endoscopic ultrasound (EUS)-guided fine needle aspiration (FNA) is considered a preferred technique for tissue sampling for solid lesions, fine needle biopsy (FNB) has recently been developed.
AIM
To compare the accuracy of FNB
vs
FNA in determining the diagnosis of solid lesions.
METHODS
A retrospective, multi-center study of EUS-guided tissue sampling using FNA
vs
FNB needles. Measured outcomes included diagnostic test characteristics (
i.e.
, sensitivity, specificity, accuracy), use of rapid on-site evaluation (ROSE), and adverse events. Subgroup analyses were performed by type of lesion and diagnostic yield with or without ROSE. A multivariable logistic regression was also performed.
RESULTS
A total of 1168 patients with solid lesions (
n
= 468 FNA;
n
= 700 FNB) underwent EUS-guided sampling. Mean age was 65.02 ± 12.13 years. Overall, sensitivity, specificity and accuracy were superior for FNB
vs
FNA (84.70%
vs
74.53%; 99.29%
vs
96.62%; and 87.62%
vs
81.55%, respectively;
P
< 0.001). On subgroup analyses, sensitivity, specificity, and accuracy of FNB alone were similar to FNA + ROSE [(81.66%
vs
86.45%;
P
= 0.142), (100%
vs
100%;
P
= 1.00) and (88.40%
vs
85.43%;
P
= 0.320]. There were no difference in diagnostic yield of FNB alone
vs
FNB + ROSE (
P
> 0.05). Multivariate analysis showed no significant predictor for better accuracy. On subgroup analyses, FNB was superior to FNA for non-pancreatic lesions; however, there was no difference between the techniques among pancreatic lesions. One adverse event was reported in each group.
CONCLUSION
FNB is superior to FNA with equivalent diagnostic test characteristics compared to FNA + ROSE in the diagnosis of non-pancreatic solid lesions. Our results suggest that EUS-FNB may eliminate the need of ROSE and should be employed as a first-line method in the diagnosis of solid lesions.